Upgrade to SI Premium - Free Trial

Lipocine (LPCN)

2.13 +0.15 (7.58%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (8/6/26)

Latest Headlines

Form S-8 Lipocine Inc. June 9, 2026 4:06 PM - SEC Filing Form 8-K Lipocine Inc. For: Jun 03 June 4, 2026 4:06 PM - SEC Filing Form 4 Lipocine Inc. For: Jun 03 Filed by: Jene Jill M. June 4, 2026 4:06 PM - SEC Filing Form 4 Lipocine Inc. For: Jun 03 Filed by: Higuchi John W. June 4, 2026 4:06 PM - SEC Filing Form 4 Lipocine Inc. For: Jun 03 Filed by: Ono Richard Dana June 4, 2026 4:06 PM - SEC Filing Form 8-K Lipocine Inc. For: Jun 04 June 4, 2026 9:00 AM - SEC Filing Lipocine Inc. to Host Virtual KOL Event Highlighting Unmet Needs in Postpartum Depression and the Clinical Profile of LPCN 1154 June 4, 2026 8:00 AM - PR NewsWire Form 8-K Lipocine Inc. For: May 26 May 26, 2026 5:08 PM - SEC Filing Form 8-K Lipocine Inc. For: May 19 May 19, 2026 9:00 AM - SEC Filing Lipocine phase 3 data for LPCN 1154 accepted for ASCP meeting presentation May 19, 2026 8:01 AM - StreetInsider Lipocine Announces LPCN 1154 Phase 3 Data Accepted for Oral Presentation at 2026 ASCP Annual Meeting May 19, 2026 8:00 AM - PR NewsWire Anaveon Strengthens Leadership Team with Appointments of Eric Zanelli as Chief Scientific Officer and Jill Jene as Chief Business Officer May 19, 2026 4:00 AM - StreetInsider Form 8-K Lipocine Inc. For: May 18 May 18, 2026 9:00 AM - SEC Filing Lipocine to Present at A.G.P.'s Annual Virtual Healthcare Company Showcase May 18, 2026 8:01 AM - PR NewsWire Form SCHEDULE 13G Lipocine Inc. Filed by: Ikarian Capital, LLC May 15, 2026 5:05 PM - SEC Filing Form SCHEDULE 13G/A Lipocine Inc. Filed by: Squadron Capital Management LLC May 15, 2026 11:56 AM - SEC Filing Lipocine (LPCN) Misses Q1 EPS by 54c May 7, 2026 6:18 PM - StreetInsider Form 8-K Lipocine Inc. For: May 07 May 7, 2026 4:11 PM - SEC Filing Lipocine Announces Financial Results for the First Quarter Ended March 31, 2026 May 7, 2026 4:05 PM - PR NewsWire Form 8-K Lipocine Inc. For: May 07 May 7, 2026 9:05 AM - SEC Filing Form 10-Q Lipocine Inc. For: Mar 31 May 7, 2026 9:01 AM - SEC Filing Form DEFA14A Lipocine Inc. April 21, 2026 5:13 PM - SEC Filing Form DEF 14A Lipocine Inc. For: Apr 21 April 21, 2026 5:01 PM - SEC Filing Form 8-K Lipocine Inc. For: Apr 16 April 21, 2026 4:06 PM - SEC Filing Form 4 Lipocine Inc. For: Apr 07 Filed by: Higuchi John W. April 7, 2026 6:27 PM - SEC Filing Form 4 Lipocine Inc. For: Apr 06 Filed by: Higuchi John W. April 6, 2026 7:11 PM - SEC Filing Form 4 Lipocine Inc. For: Apr 06 Filed by: Patel Mahesh V. April 6, 2026 6:43 PM - SEC Filing H.C. Wainwright Downgrades Lipocine Inc (LPCN) to Neutral April 6, 2026 6:07 AM - StreetInsider Form 4 Lipocine Inc. For: Apr 02 Filed by: Patel Mahesh V. April 2, 2026 5:06 PM - SEC Filing Form 8-K Lipocine Inc. For: Apr 02 April 2, 2026 9:40 AM - SEC Filing Form 8-K Lipocine Inc. For: Apr 02 April 2, 2026 9:35 AM - SEC Filing Lipocine's postpartum depression drug fails primary endpoint in phase 3 trial April 2, 2026 8:02 AM - StreetInsider Lipocine Reports Topline Safety and Efficacy Results for LPCN 1154 in Patients with Postpartum Depression April 2, 2026 8:00 AM - PR NewsWire Full Article List